Neutrophil elastase alpha 1-proteinase inhibitor complexes in pleural effusions

Area of Science:

• Pulmonology
• Biochemistry
• Oncology

Background:

• Neutrophil elastase (NE) is neutralized by alpha 1-proteinase inhibitor (alpha 1 PI) in vivo.
• Elastase alpha 1-proteinase inhibitor complexes (E-alpha 1 PI) form when NE is active.
• Assessing E-alpha 1 PI in pleural effusions may offer diagnostic value.

Purpose of the Study:

• To evaluate the clinical utility of E-alpha 1 PI concentrations in pleural effusions.
• To differentiate between malignant, non-malignant exudates, and transudates.
• To explore E-alpha 1 PI as a marker for pleural fluid inflammation and malignancy.

Main Methods:

• Analysis of pleural fluid samples from 99 patients with various effusion types.
• Measurement of E-alpha 1 PI concentrations in all samples.
• Comparison of E-alpha 1 PI levels with effusion characteristics (malignancy, protein content, cell counts).

Main Results:

• Non-malignant exudates had significantly higher E-alpha 1 PI concentrations than malignant effusions or transudates.
• Malignant effusions from lung cancer showed higher E-alpha 1 PI than those from extrathoracic malignancies.
• Low E-alpha 1 PI levels (<75 ng/ml) in high-protein exudates were characteristic of malignancy.

Conclusions:

• E-alpha 1 PI complexes in pleural fluid reflect inflammation stage more than leukocyte counts.
• Low E-alpha 1 PI levels in protein-rich pleural exudates are indicative of malignancy.
• E-alpha 1 PI determination is a sensitive marker for inflammation and a useful adjunct for diagnosing pleural effusions.